GSK plc - Ordinary Shares and American Depositary Shares (GSK)

CUSIP: 37733W204

Q2 2017 13F Holders as of 30 Jun 2017

Holder snapshot 3 signals
Share change
0
SEC-reported price per share
$43.12
Indexed holders
2
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
4,029,280,651

Security key

37733W204

Report period

Q2 2017

Indexed institutions

2

Top holders

3

Ownership snapshot

Top reported holders of GSK - GSK plc - Ordinary Shares and American Depositary Shares (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
0/15
Latest evidence
31 Mar 2017
13F Highest disclosed value: $996,452,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

FMR LLC has the largest disclosed position value at $996.45M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens FMR LLC's linked filing trail.
Disclosed position value Top 5
FMR LLC $996.45M
Fisher Asset Management, LLC $504.65M
WELLS FARGO & COMPANY/MN $491.37M
PRICE T ROWE ASSOCIATES INC /MD/ $450.21M
STATE STREET CORP $442.34M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
FMR LLC
13F
Company
13F
—
denominator unverified
$996,452,000
23,635,038 shares
— 31 Mar 2017
Fisher Asset Management, LLC
13F
Company
13F
—
denominator unverified
$504,650,000
11,969,866 shares
— 31 Mar 2017
WELLS FARGO & COMPANY/MN
13F
Company
13F
—
denominator unverified
$491,368,000
11,654,851 shares
— 31 Mar 2017
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
13F
—
denominator unverified
$450,208,000
10,678,557 shares
— 31 Mar 2017
STATE STREET CORP
13F
Company
13F
—
denominator unverified
$442,338,000
10,491,299 shares
— 31 Mar 2017
ROYAL BANK OF CANADA
13F
Company
13F
—
denominator unverified
$367,134,000
8,708,084 shares
— 31 Mar 2017
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2017

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
2
Shares
20,700
Indexed holders
2
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q2 2017 vs Q1 2017 Across Filers

Q1 2017 indexed holders
2
Q2 2017 indexed holders
2
Indexed holder difference
0
Investor Q1 2017 Shares Q2 2017 Shares Share Diff Share Chg % Q1 2017 value Q2 2017 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .